Hebei Changshan Biochem Pharma (300255) — Capital Reinvestment Ratio
Hebei Changshan Biochem Pharma (300255) has a Capital Reinvestment Ratio of 0.27x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥70.22 Million) in capital expenditures (CN¥18.63 Million). See 300255 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hebei Changshan Biochem Pharma Capital Reinvestment Ratio (2009–2024)
This chart tracks Hebei Changshan Biochem Pharma's Capital Reinvestment Ratio across 10 annual periods. Check Hebei Changshan Biochem Pharma total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Hebei Changshan Biochem Pharma (2009–2024)
Year-by-year Capital Reinvestment Ratio for Hebei Changshan Biochem Pharma from 2009 to 2024. For live market cap and broader valuation context, see how much is Hebei Changshan Biochem Pharma worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 4.26x | CN¥56.22 Million | CN¥239.59 Million | ▼ -39.9% |
| 2023 | 7.10x | CN¥33.73 Million | CN¥239.32 Million | ▼ -94.9% |
| 2022 | 137.97x | CN¥3.13 Million | CN¥431.22 Million | ▲ +28.6% |
| 2021 | 107.29x | CN¥2.87 Million | CN¥308.08 Million | ▲ +13277.0% |
| 2018 | 0.80x | CN¥292.81 Million | CN¥234.85 Million | ▼ -17.8% |
| 2017 | 0.98x | CN¥162.28 Million | CN¥158.30 Million | ▲ +73.8% |
| 2016 | 0.56x | CN¥171.96 Million | CN¥96.52 Million | ▼ -68.6% |
| 2011 | 1.79x | CN¥17.04 Million | CN¥30.43 Million | ▲ +39.0% |
| 2010 | 1.28x | CN¥29.25 Million | CN¥37.56 Million | ▲ +29.3% |
| 2009 | 0.99x | CN¥24.21 Million | CN¥24.05 Million | — |